Click for best price

Injectable Targeted Therapy Market Size, Share 2022

Market Analysis and Insights: Global Injectable Targeted Therapy Market

The global Injectable Targeted Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Injectable Targeted Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Injectable Targeted Therapy market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Injectable Targeted Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Injectable Targeted Therapy market.

Global Injectable Targeted Therapy Scope and Market Size

Injectable Targeted Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Injectable Targeted Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Monoclonal Antibodies

Small-Molecules

Immunotoxins

Others

Segment by Application

Hospitals

Homecare

Specialty Clinics

Others

By Company

Novartis

Sanofi

GSK

Bayer

Amgen

Merck

AbbiVie

AstraZeneca

Teva

Roche

Pfizer

By Region

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The information for each competitor/Company Profile includes:

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Injectable Targeted Therapy product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Injectable Targeted Therapy, with price, sales, revenue, and global market share of Injectable Targeted Therapy from 2019 to 2022.

Chapter 3, the Injectable Targeted Therapy competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Injectable Targeted Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Injectable Targeted Therapy market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Injectable Targeted Therapy.

Chapter 13, 14, and 15, to describe Injectable Targeted Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 Injectable Targeted Therapy Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes	Report Details
Report Title	Global Injectable Targeted Therapy Market Insights and Forecast to 2028
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2021
Forecast Year	2029
Number of Pages	107 Pages
Customization Available	Yes, the report can be customized as per your need.

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Targeted Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monoclonal Antibodies
1.2.3 Small-Molecules
1.2.4 Immunotoxins
1.2.5 Others
1.3 Market by Application
1.3.1 Global Injectable Targeted Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Injectable Targeted Therapy Market Perspective (2017-2028)
2.2 Injectable Targeted Therapy Growth Trends by Region
2.2.1 Injectable Targeted Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Injectable Targeted Therapy Historic Market Size by Region (2017-2022)
2.2.3 Injectable Targeted Therapy Forecasted Market Size by Region (2023-2028)
2.3 Injectable Targeted Therapy Market Dynamics
2.3.1 Injectable Targeted Therapy Industry Trends
2.3.2 Injectable Targeted Therapy Market Drivers
2.3.3 Injectable Targeted Therapy Market Challenges
2.3.4 Injectable Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Injectable Targeted Therapy Players by Revenue
3.1.1 Global Top Injectable Targeted Therapy Players by Revenue (2017-2022)
3.1.2 Global Injectable Targeted Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Injectable Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Injectable Targeted Therapy Revenue
3.4 Global Injectable Targeted Therapy Market Concentration Ratio
3.4.1 Global Injectable Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Targeted Therapy Revenue in 2021
3.5 Injectable Targeted Therapy Key Players Head office and Area Served
3.6 Key Players Injectable Targeted Therapy Product Solution and Service
3.7 Date of Enter into Injectable Targeted Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Injectable Targeted Therapy Breakdown Data by Type
4.1 Global Injectable Targeted Therapy Historic Market Size by Type (2017-2022)
4.2 Global Injectable Targeted Therapy Forecasted Market Size by Type (2023-2028)
5 Injectable Targeted Therapy Breakdown Data by Application
5.1 Global Injectable Targeted Therapy Historic Market Size by Application (2017-2022)
5.2 Global Injectable Targeted Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Injectable Targeted Therapy Market Size (2017-2028)
6.2 North America Injectable Targeted Therapy Market Size by Type
6.2.1 North America Injectable Targeted Therapy Market Size by Type (2017-2022)
6.2.2 North America Injectable Targeted Therapy Market Size by Type (2023-2028)
6.2.3 North America Injectable Targeted Therapy Market Share by Type (2017-2028)
6.3 North America Injectable Targeted Therapy Market Size by Application
6.3.1 North America Injectable Targeted Therapy Market Size by Application (2017-2022)
6.3.2 North America Injectable Targeted Therapy Market Size by Application (2023-2028)
6.3.3 North America Injectable Targeted Therapy Market Share by Application (2017-2028)
6.4 North America Injectable Targeted Therapy Market Size by Country
6.4.1 North America Injectable Targeted Therapy Market Size by Country (2017-2022)
6.4.2 North America Injectable Targeted Therapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Injectable Targeted Therapy Market Size (2017-2028)
7.2 Europe Injectable Targeted Therapy Market Size by Type
7.2.1 Europe Injectable Targeted Therapy Market Size by Type (2017-2022)
7.2.2 Europe Injectable Targeted Therapy Market Size by Type (2023-2028)
7.2.3 Europe Injectable Targeted Therapy Market Share by Type (2017-2028)
7.3 Europe Injectable Targeted Therapy Market Size by Application
7.3.1 Europe Injectable Targeted Therapy Market Size by Application (2017-2022)
7.3.2 Europe Injectable Targeted Therapy Market Size by Application (2023-2028)
7.3.3 Europe Injectable Targeted Therapy Market Share by Application (2017-2028)
7.4 Europe Injectable Targeted Therapy Market Size by Country
7.4.1 Europe Injectable Targeted Therapy Market Size by Country (2017-2022)
7.4.2 Europe Injectable Targeted Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Injectable Targeted Therapy Market Size (2017-2028)
8.2 Asia-Pacific Injectable Targeted Therapy Market Size by Type
8.2.1 Asia-Pacific Injectable Targeted Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Injectable Targeted Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Injectable Targeted Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Injectable Targeted Therapy Market Size by Application
8.3.1 Asia-Pacific Injectable Targeted Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Injectable Targeted Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Injectable Targeted Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Injectable Targeted Therapy Market Size by Region
8.4.1 Asia-Pacific Injectable Targeted Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Injectable Targeted Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Injectable Targeted Therapy Market Size (2017-2028)
9.2 Latin America Injectable Targeted Therapy Market Size by Type
9.2.1 Latin America Injectable Targeted Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Injectable Targeted Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Injectable Targeted Therapy Market Share by Type (2017-2028)
9.3 Latin America Injectable Targeted Therapy Market Size by Application
9.3.1 Latin America Injectable Targeted Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Injectable Targeted Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Injectable Targeted Therapy Market Share by Application (2017-2028)
9.4 Latin America Injectable Targeted Therapy Market Size by Country
9.4.1 Latin America Injectable Targeted Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Injectable Targeted Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Injectable Targeted Therapy Market Size (2017-2028)
10.2 Middle East & Africa Injectable Targeted Therapy Market Size by Type
10.2.1 Middle East & Africa Injectable Targeted Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Injectable Targeted Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Injectable Targeted Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Injectable Targeted Therapy Market Size by Application
10.3.1 Middle East & Africa Injectable Targeted Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Injectable Targeted Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Injectable Targeted Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Injectable Targeted Therapy Market Size by Country
10.4.1 Middle East & Africa Injectable Targeted Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Injectable Targeted Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Injectable Targeted Therapy Introduction
11.1.4 Novartis Revenue in Injectable Targeted Therapy Business (2017-2022)
11.1.5 Novartis Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Injectable Targeted Therapy Introduction
11.2.4 Sanofi Revenue in Injectable Targeted Therapy Business (2017-2022)
11.2.5 Sanofi Recent Developments
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Injectable Targeted Therapy Introduction
11.3.4 GSK Revenue in Injectable Targeted Therapy Business (2017-2022)
11.3.5 GSK Recent Developments
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Injectable Targeted Therapy Introduction
11.4.4 Bayer Revenue in Injectable Targeted Therapy Business (2017-2022)
11.4.5 Bayer Recent Developments
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Injectable Targeted Therapy Introduction
11.5.4 Amgen Revenue in Injectable Targeted Therapy Business (2017-2022)
11.5.5 Amgen Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Injectable Targeted Therapy Introduction
11.6.4 Merck Revenue in Injectable Targeted Therapy Business (2017-2022)
11.6.5 Merck Recent Developments
11.7 AbbiVie
11.7.1 AbbiVie Company Details
11.7.2 AbbiVie Business Overview
11.7.3 AbbiVie Injectable Targeted Therapy Introduction
11.7.4 AbbiVie Revenue in Injectable Targeted Therapy Business (2017-2022)
11.7.5 AbbiVie Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Injectable Targeted Therapy Introduction
11.8.4 AstraZeneca Revenue in Injectable Targeted Therapy Business (2017-2022)
11.8.5 AstraZeneca Recent Developments
11.9 Teva
11.9.1 Teva Company Details
11.9.2 Teva Business Overview
11.9.3 Teva Injectable Targeted Therapy Introduction
11.9.4 Teva Revenue in Injectable Targeted Therapy Business (2017-2022)
11.9.5 Teva Recent Developments
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Injectable Targeted Therapy Introduction
11.10.4 Roche Revenue in Injectable Targeted Therapy Business (2017-2022)
11.10.5 Roche Recent Developments
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Injectable Targeted Therapy Introduction
11.11.4 Pfizer Revenue in Injectable Targeted Therapy Business (2017-2022)
11.11.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Injectable Targeted Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Small-Molecules
Table 4. Key Players of Immunotoxins
Table 5. Key Players of Others
Table 6. Global Injectable Targeted Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Injectable Targeted Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Injectable Targeted Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Injectable Targeted Therapy Market Share by Region (2017-2022)
Table 10. Global Injectable Targeted Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Injectable Targeted Therapy Market Share by Region (2023-2028)
Table 12. Injectable Targeted Therapy Market Trends
Table 13. Injectable Targeted Therapy Market Drivers
Table 14. Injectable Targeted Therapy Market Challenges
Table 15. Injectable Targeted Therapy Market Restraints
Table 16. Global Injectable Targeted Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Injectable Targeted Therapy Revenue Share by Players (2017-2022)
Table 18. Global Top Injectable Targeted Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Targeted Therapy as of 2021)
Table 19. Ranking of Global Top Injectable Targeted Therapy Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Injectable Targeted Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Injectable Targeted Therapy Product Solution and Service
Table 23. Date of Enter into Injectable Targeted Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Injectable Targeted Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Injectable Targeted Therapy Revenue Market Share by Type (2017-2022)
Table 27. Global Injectable Targeted Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Injectable Targeted Therapy Revenue Market Share by Type (2023-2028)
Table 29. Global Injectable Targeted Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Injectable Targeted Therapy Revenue Share by Application (2017-2022)
Table 31. Global Injectable Targeted Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Injectable Targeted Therapy Revenue Share by Application (2023-2028)
Table 33. North America Injectable Targeted Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Injectable Targeted Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Injectable Targeted Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Injectable Targeted Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Injectable Targeted Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Injectable Targeted Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Injectable Targeted Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Injectable Targeted Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Injectable Targeted Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Injectable Targeted Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Injectable Targeted Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Injectable Targeted Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Injectable Targeted Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Injectable Targeted Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Injectable Targeted Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Injectable Targeted Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Injectable Targeted Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Injectable Targeted Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Injectable Targeted Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Injectable Targeted Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Injectable Targeted Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Injectable Targeted Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Injectable Targeted Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Injectable Targeted Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Injectable Targeted Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Injectable Targeted Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Injectable Targeted Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Injectable Targeted Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Injectable Targeted Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Injectable Targeted Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Injectable Targeted Therapy Product
Table 66. Novartis Revenue in Injectable Targeted Therapy Business (2017-2022) & (US$ Million)
Table 67. Novartis Recent Developments
Table 68. Sanofi Company Details
Table 69. Sanofi Business Overview
Table 70. Sanofi Injectable Targeted Therapy Product
Table 71. Sanofi Revenue in Injectable Targeted Therapy Business (2017-2022) & (US$ Million)
Table 72. Sanofi Recent Developments
Table 73. GSK Company Details
Table 74. GSK Business Overview
Table 75. GSK Injectable Targeted Therapy Product
Table 76. GSK Revenue in Injectable Targeted Therapy Business (2017-2022) & (US$ Million)
Table 77. GSK Recent Developments
Table 78. Bayer Company Details
Table 79. Bayer Business Overview
Table 80. Bayer Injectable Targeted Therapy Product
Table 81. Bayer Revenue in Injectable Targeted Therapy Business (2017-2022) & (US$ Million)
Table 82. Bayer Recent Developments
Table 83. Amgen Company Details
Table 84. Amgen Business Overview
Table 85. Amgen Injectable Targeted Therapy Product
Table 86. Amgen Revenue in Injectable Targeted Therapy Business (2017-2022) & (US$ Million)
Table 87. Amgen Recent Developments
Table 88. Merck Company Details
Table 89. Merck Business Overview
Table 90. Merck Injectable Targeted Therapy Product
Table 91. Merck Revenue in Injectable Targeted Therapy Business (2017-2022) & (US$ Million)
Table 92. Merck Recent Developments
Table 93. AbbiVie Company Details
Table 94. AbbiVie Business Overview
Table 95. AbbiVie Injectable Targeted Therapy Product
Table 96. AbbiVie Revenue in Injectable Targeted Therapy Business (2017-2022) & (US$ Million)
Table 97. AbbiVie Recent Developments
Table 98. AstraZeneca Company Details
Table 99. AstraZeneca Business Overview
Table 100. AstraZeneca Injectable Targeted Therapy Product
Table 101. AstraZeneca Revenue in Injectable Targeted Therapy Business (2017-2022) & (US$ Million)
Table 102. AstraZeneca Recent Developments
Table 103. Teva Company Details
Table 104. Teva Business Overview
Table 105. Teva Injectable Targeted Therapy Product
Table 106. Teva Revenue in Injectable Targeted Therapy Business (2017-2022) & (US$ Million)
Table 107. Teva Recent Developments
Table 108. Roche Company Details
Table 109. Roche Business Overview
Table 110. Roche Injectable Targeted Therapy Product
Table 111. Roche Revenue in Injectable Targeted Therapy Business (2017-2022) & (US$ Million)
Table 112. Roche Recent Developments
Table 113. Pfizer Company Details
Table 114. Pfizer Business Overview
Table 115. Pfizer Injectable Targeted Therapy Product
Table 116. Pfizer Revenue in Injectable Targeted Therapy Business (2017-2022) & (US$ Million)
Table 117. Pfizer Recent Developments
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Injectable Targeted Therapy Market Share by Type: 2021 VS 2028
Figure 2. Monoclonal Antibodies Features
Figure 3. Small-Molecules Features
Figure 4. Immunotoxins Features
Figure 5. Others Features
Figure 6. Global Injectable Targeted Therapy Market Share by Application: 2021 VS 2028
Figure 7. Hospitals Case Studies
Figure 8. Homecare Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Injectable Targeted Therapy Report Years Considered
Figure 12. Global Injectable Targeted Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Injectable Targeted Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Injectable Targeted Therapy Market Share by Region: 2021 VS 2028
Figure 15. Global Injectable Targeted Therapy Market Share by Players in 2021
Figure 16. Global Top Injectable Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Targeted Therapy as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Injectable Targeted Therapy Revenue in 2021
Figure 18. North America Injectable Targeted Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Injectable Targeted Therapy Market Size Market Share by Type (2017-2028)
Figure 20. North America Injectable Targeted Therapy Market Size Market Share by Application (2017-2028)
Figure 21. North America Injectable Targeted Therapy Market Size Share by Country (2017-2028)
Figure 22. United States Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Injectable Targeted Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Injectable Targeted Therapy Market Size Market Share by Type (2017-2028)
Figure 26. Europe Injectable Targeted Therapy Market Size Market Share by Application (2017-2028)
Figure 27. Europe Injectable Targeted Therapy Market Size Share by Country (2017-2028)
Figure 28. Germany Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Injectable Targeted Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Injectable Targeted Therapy Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Injectable Targeted Therapy Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Injectable Targeted Therapy Market Size Share by Region (2017-2028)
Figure 38. China Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Injectable Targeted Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Injectable Targeted Therapy Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Injectable Targeted Therapy Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Injectable Targeted Therapy Market Size Share by Country (2017-2028)
Figure 48. Mexico Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Injectable Targeted Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Injectable Targeted Therapy Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Injectable Targeted Therapy Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Injectable Targeted Therapy Market Size Share by Country (2017-2028)
Figure 54. Turkey Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Injectable Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Novartis Revenue Growth Rate in Injectable Targeted Therapy Business (2017-2022)
Figure 58. Sanofi Revenue Growth Rate in Injectable Targeted Therapy Business (2017-2022)
Figure 59. GSK Revenue Growth Rate in Injectable Targeted Therapy Business (2017-2022)
Figure 60. Bayer Revenue Growth Rate in Injectable Targeted Therapy Business (2017-2022)
Figure 61. Amgen Revenue Growth Rate in Injectable Targeted Therapy Business (2017-2022)
Figure 62. Merck Revenue Growth Rate in Injectable Targeted Therapy Business (2017-2022)
Figure 63. AbbiVie Revenue Growth Rate in Injectable Targeted Therapy Business (2017-2022)
Figure 64. AstraZeneca Revenue Growth Rate in Injectable Targeted Therapy Business (2017-2022)
Figure 65. Teva Revenue Growth Rate in Injectable Targeted Therapy Business (2017-2022)
Figure 66. Roche Revenue Growth Rate in Injectable Targeted Therapy Business (2017-2022)
Figure 67. Pfizer Revenue Growth Rate in Injectable Targeted Therapy Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

REPORT PURCHASE OPTIONS

Single User Price : $4667

Multi User Price : $7000

Enterprise Price : $9333

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global Injectable Targeted Therapy Market Insights and Forecast to 2028